Department of Public Health and Primary Care, Ghent University, Campus University Hospital Ghent, entrance 42, 4K3, Corneel Heymanslaan 10, 9000, Ghent, Belgium.
Department of Cardiovascular, Respiratory, Nephrological, Anesthesiological and Geriatric Sciences, Sapienza University of Rome, Rome, Italy.
Sci Rep. 2021 Mar 11;11(1):5663. doi: 10.1038/s41598-021-84920-4.
This study tested the effectiveness of HeartMan-a mobile personal health system offering decisional support for management of congestive heart failure (CHF)-on health-related quality of life (HRQoL), self-management, exercise capacity, illness perception, mental and sexual health. A randomized controlled proof-of-concept trial (1:2 ratio of control:intervention) was set up with ambulatory CHF patients in stable condition in Belgium and Italy. Data were collected by means of a 6-min walking test and a number of standardized questionnaire instruments. A total of 56 (34 intervention and 22 control group) participants completed the study (77% male; mean age 63 years, sd 10.5). All depression and anxiety dimensions decreased in the intervention group (p < 0.001), while the need for sexual counselling decreased in the control group (p < 0.05). Although the group differences were not significant, self-care increased (p < 0.05), and sexual problems decreased (p < 0.05) in the intervention group only. No significant intervention effects were observed for HRQoL, self-care confidence, illness perception and exercise capacity. Overall, results of this proof-of-concept trial suggest that the HeartMan personal health system significantly improved mental and sexual health and self-care behaviour in CHF patients. These observations were in contrast to the lack of intervention effects on HRQoL, illness perception and exercise capacity.
这项研究测试了 HeartMan 的有效性，HeartMan 是一种提供充血性心力衰竭（CHF）管理决策支持的移动个人健康系统，它对健康相关生活质量（HRQoL）、自我管理、运动能力、疾病认知、心理健康和性健康都有影响。该研究采用比利时和意大利稳定状态下的门诊 CHF 患者，进行了一项随机对照概念验证试验（1:2 的对照：干预比例）。通过 6 分钟步行测试和一些标准化问卷工具收集数据。共有 56 名（34 名干预组和 22 名对照组）参与者完成了研究（77%为男性；平均年龄 63 岁，标准差 10.5）。所有抑郁和焦虑维度在干预组中均有所下降（p<0.001），而对照组的性咨询需求下降（p<0.05）。尽管组间差异不显著，但仅在干预组中自我护理增加（p<0.05），性问题减少（p<0.05）。在 HRQoL、自我护理信心、疾病认知和运动能力方面，没有观察到显著的干预效果。总的来说，这项概念验证试验的结果表明，HeartMan 个人健康系统显著改善了 CHF 患者的心理健康和性健康以及自我护理行为。这些观察结果与 HRQoL、疾病认知和运动能力缺乏干预效果形成对比。
